Intec Parent is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, which Co. refers to as the Accordion Pill. Co.'s primary product candidate, Accordion Pill Carbidopa/Levodopa is being developed for the indication of treatment of Parkinson's disease symptoms in Parkinson's disease patients. In addition, Co. has initiated a clinical development program for its Accordion Pill platform with the two primary cannabinoids contained in cannabis sativa, which it refers to as AP-Cannabinoids. Co. is formulating and testing Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various pain indications.